Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

BACKGROUND: Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of UC. We aimed to describe the real-world treatment experience and corticosteroid utilisation of patients treated with tofacitinib in a US claims database. METHODS: Patients with a UC diagnosis who initiated tofaciti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiorean, Michael V., Allegretti, Jessica R., Sharma, Puza P., Chastek, Benjamin, Salese, Leonardo, Bell, Elizabeth J., Peterson-Brandt, Jesse, Cappelleri, Joseph C., Guo, Xiang, Khan, Nabeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994921/
https://www.ncbi.nlm.nih.gov/pubmed/35397501
http://dx.doi.org/10.1186/s12876-022-02215-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994921/
https://www.ncbi.nlm.nih.gov/pubmed/35397501
http://dx.doi.org/10.1186/s12876-022-02215-y

Ejemplares similares